Delivery Order SPE2DR25D3016-SPE2DR26FG3LC
Award Date 1/15/26
Potential Completion Date 2/6/26
Potential Value $28K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $55,488.06 for Benlysta 200 mg/ml auto-injectors on September 17, 2025, with an ultimate completion date of October 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/mL auto-injector on November 25, 2025, with completion scheduled for December 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. BENLYSTA (belimumab) is a biologic medication used primarily to treat systemic lupus erythematosus and other...
- The Defense Logistics Agency awarded a $3,082.67 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on November 10, 2025, with completion expected by December 3, 2025. This competitively awarded, firm fixed-price order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Benlysta (belimumab) is a monoclonal antibody used to treat systemic lupus erythematosus and is supplied through auto-injector...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector units valued at $6,165.34, with a completion deadline of July 23, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. Benlysta (belimumab) is a monoclonal antibody therapy used to treat systemic lupus erythematosus, and the auto-injector formulation facilitates...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/ml auto-injector on October 21, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. BENLYSTA (belimumab) is a monoclonal antibody used to treat systemic lupus...
- The Defense Logistics Agency awarded a $3,486.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on January 7, 2026, with completion scheduled for January 29, 2026. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as the primary vehicle for supplying pharmaceutical products and medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/mL auto-injector on December 29, 2025, with an ultimate completion date of January 21, 2026. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. BENLYSTA (belimumab) is a monoclonal antibody used to treat systemic lupus erythematosus and...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/mL auto-injector on December 4, 2025, with completion scheduled for December 26, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through the federal procurement process. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors on November 3, 2025, with an ultimate completion date of November 25, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Benlysta (belimumab) is a monoclonal antibody therapy indicated for systemic lupus erythematosus, representing a...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award leverages AmerisourceBergen's established relationship with DLA to supply...